Description

Schanz et al reported a comprehensive scoring system based on cytogenetics for patients with primary myelodysplasia (MDS) or oligoblastic acute myeloid leukemia (AML). This can help to identify a patient who may benefit from more aggressive management. The authors are from multiple institutions from around the world.


 

Patient selection: primary myelodysplastic syndrome or oligoblastic acute myeloid leukemia

 

Parameters:

(1) total number of cytogenetic abnormalities

(2) specific cytogenetic abnormalities

Total Number

Specific Cytogenetic Abnormalities

Prognosis

>= 4

NA

very poor

3

NA

poor

2

del(5q) OR -7

poor

2

del(7q)

good

2

other

intermediate

1

inv(3) OR t(3q) OR del(3q) OR -7

poor

1

del(11q) OR -Y

very good

1

del(5q) OR del(12p) OR del(20q)

good

1

del(7q) OR +8 OR i(17q) OR +19

intermediate

1

independent clones

intermediate

1

other

intermediate

0 (none)

NA

good

 


To read more or access our algorithms and calculators, please log in or register.